On the recordFebruary 8, 2024
Biosimilar competition is one way to drive down drug costs for patients and increase access.
Source
congress.govEditor's note · Context
Lujan advocates for biosimilar competition to lower drug costs and improve access for patients.
Share
More from Ben Ray Luján
Jul 2, 2026
While the Supreme Court rejected those efforts this time, Congress must reassert its legal authority and hold the president accountable as he seeks to rewrite the law in his favor.
Jul 16, 2026
“Over the past several years, we’ve seen far too many reports detailing how lavish gifts and luxury travel have undermined public confidence in the Supreme Court,”
Jun 25, 2026
Women deserve the freedom to make their own health care decisions without interference from politicians.
Jun 16, 2026
In a country as abundant as the United States, allowing our neighbors to go hungry is a policy choice, not an inevitability.
Other voices in this conversation
